Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05495256 · ClinicalTrials.gov registry record · NA
Monitoring Metered Dose Inhalation (MDI) Volume and Timing With a Respimetrix Device in Obstructive Lung Disease.
A NA study of Asthma and COPD, sponsored by Pulmonary Critical Care Associates of Baltimore.
- Completed
- Registry status
- NA
- Development phase
- 74
- Enrollment target
- 1
- Study location
NCT05495256: Completed NA study of Asthma and COPD, sponsored by Pulmonary Critical Care Associates of Baltimore.
NCT05495256 is a NA study of Asthma and COPD that has completed, run by Pulmonary Critical Care Associates of Baltimore. The registered enrollment target is 74 participants, below the 1,563-participant average among 374 other Asthma trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05495256, a NA study of Asthma and COPD, has completed, sponsored by Pulmonary Critical Care Associates of Baltimore.
- COMPLETED
- Registry status
- NA
- Development phase
- 74 participants
- Enrollment target
- 1
- Study location
Study Summary
To Determine whether use of the Respimetrix flow test device a) can determine "good" versus "poor" inhaler techniques, and b) the effects of the inhaler training on technique.
Primary Outcome
Measure actuation timing, flow rate and volume after intervention
Interventions
- DEVICE Respimetrix
Study Locations (1)
Maryland
- Pulmonary and Critical Care Associates Of Baltimor - Towson
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 74 participants |
| Start Date | 2021-05-01 |
| Est. Completion | 2022-03-22 |
| Phase | NA |
What the finished NCT05495256 record still lists
NCT05495256 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 74 participants, a relatively small participant target, below the 1,563-participant average among 374 other Asthma trials with a reported enrollment target (95% lower).
The record links to 2 conditions, with Asthma appearing as the primary indexed condition, and to 1 intervention - of which Respimetrix is the first listed.
NCT05495256 reports a single indexed study location in Maryland.
Frequently Asked Questions
What is clinical trial NCT05495256 about?
NCT05495256 is a clinical study titled "Monitoring Metered Dose Inhalation (MDI) Volume and Timing With a Respimetrix Device in Obstructive Lung Disease.". To Determine whether use of the Respimetrix flow test device a) can determine "good" versus "poor" inhaler techniques, and b) the effects of the inhaler training on technique.
What is the current status of trial NCT05495256?
This trial is currently completed. It is a NA study. The enrollment target is 74 participants. The study started on 2021-05-01. Estimated completion is 2022-03-22.
What conditions does trial NCT05495256 study?
This clinical trial studies the following conditions: Asthma, COPD.
What interventions are being tested in trial NCT05495256?
The interventions under investigation include: Respimetrix (DEVICE).
Who is sponsoring clinical trial NCT05495256?
This trial is sponsored by Pulmonary Critical Care Associates of Baltimore, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05495256 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Asthma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05495256's enrollment target sits among peer trials
74 236th of 374 higher than 139 of 374 other Asthma trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Asthma trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Automated Inhaler Monitoring for Asthma Medication Usage
RECRUITING · NA
-
Reducing Overuse of Antibiotics With Decision Support
RECRUITING · NA
-
ASTHMAXcel Voice Study
RECRUITING · NA
-
Home Hospital for Suddenly Ill Adults
RECRUITING · NA
-
Asthma and Technology in Emerging African American Adults
RECRUITING · NA
-
BREATHE: An Efficacy-implementation Trial Among Black Adults With Uncontrolled Asthma
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03422731 · 74 participants · Early Phase 1
Multi-modality Imaging and Collection of Biospecimen Samples in Understanding Bone Marrow Changes in Patients With Acute Myeloid Leukemia Undergoing TBI and Chemotherapy
- NCT03804853 · 74 participants · NA
Rehabilitation Following Reverse Total Shoulder Arthroplasty
- NCT04065776 · 74 participants · NA
Evaluation of Hippocampal-Avoidance Using Proton Therapy in Low-Grade Glioma
- NCT04771156 · 74 participants · Phase 4
Ketorolac in Palatoplasty
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI